Julie E. Stein

Johns Hopkins University — United States

Medicine · Health Sciences

18h-index3.1kcitations91works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(70), Immunotherapy and Immune Responses(55), T-cell and B-cell Immunology(40), CAR-T cell therapy research(11), Cancer Genomics and Diagnostics(7)

Publications91 total

Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker Discovery
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Janis M. Taube(41), Evan J. Lipson(23), Kara M. Schenk(16), Jennifer A. Wargo(15), John M. Kirkwood(15), Suzanne L. Topalian(14), Maryam Pourmaleki(14), Caitlin J. Jones(14), Charlotte E. Ariyan(14), Zheng Zeng(14), Mono Pirun(14), Daniel A. Navarrete(14), Yanyun Li(14), Mianlei Zhang(14), Subhiksha Nandakumar(14), Carl Campos(14), Saad Nadeem(14), David S. Klimstra(14), Claire Temple‐Oberle(14), Thomas Brenn(14)